Search by Drug Name or NDC

    NDC 43386-0862-01 Dexmethylphenidate Hydrochloride 2.5 mg/1 Details

    Dexmethylphenidate Hydrochloride 2.5 mg/1

    Dexmethylphenidate Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals,Inc.. The primary component is DEXMETHYLPHENIDATE HYDROCHLORIDE.

    Product Information

    NDC 43386-0862
    Product ID 43386-862_b1300c71-14cf-482b-9f82-089e5d084939
    Associated GPIs 61400016100320
    GCN Sequence Number 048982
    GCN Sequence Number Description dexmethylphenidate HCl TABLET 2.5 MG ORAL
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 14973
    HICL Sequence Number 022987
    HICL Sequence Number Description DEXMETHYLPHENIDATE HCL
    Brand/Generic Generic
    Proprietary Name Dexmethylphenidate Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dexmethylphenidate Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Labeler Name Lupin Pharmaceuticals,Inc.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA204534
    Listing Certified Through 2024-12-31

    Package

    NDC 43386-0862-01 (43386086201)

    NDC Package Code 43386-862-01
    Billing NDC 43386086201
    Package 100 TABLET in 1 BOTTLE (43386-862-01)
    Marketing Start Date 2015-12-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.13719
    Pricing Unit EA
    Effective Date 2022-06-22
    NDC Description DEXMETHYLPHENIDATE 2.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-06-22
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis